Champions Oncology Reports Record Annual Revenue of $59 Million
Champions Oncology reported fiscal 2026 annual revenue of $59.4 million, a 4% year-over-year increase, achieving record fourth-quarter revenue of $13.8 million, up 12%. The company delivered positive Adjusted EBITDA of $158,000 in the fourth quarter and $1.6 million for the full year, marking four consecutive quarters of positive Adjusted EBITDA.
Key figures
- Revenue
- $59.4 million
- Revenue Yoy
- 4%
- Cash
- $4.9 million
- Adj eps
- 0.12
- Adj ebitda
- 1600000
- Q4 revenue
- $13.8 million
- Q4 adj ebitda
- 158000
- Q4 oncology services margin
- 51%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.